在线和ChatGPT生成的关于脑瘤预后的患者教育材料未能满足可读性标准
Ishav Y Shukla1, Matthew Z Sun1
1Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
概括
在线和人工智能生成的神经瘤学信息对患者来说太复杂了. 可读性评估显示,这些材料超过了推的等级水平,阻碍了质母细胞瘤,脑膜瘤和垂体腺瘤患者的知情决策.
科学领域:
- 神经瘤学神经瘤学
- 卫生识字 卫生识字
- 医疗保健中的人工智能
背景情况:
- 在线健康信息往往呈现出复杂的医学术语.
- 患者的理解对于明智的医疗决策至关重要.
- 神经瘤学信息的可访问性对于患者护理至关重要.
研究的目的:
- 评估在线和ChatGPT生成的关于脑瘤 (质母细胞瘤,脑膜瘤,垂体腺瘤) 的材料的可读性.
- 为了比较不同瘤类型,机构隶属,作者和来源 (网站与ChatGPT) 的可读性.
主要方法:
- 横截面研究分析谷歌搜索结果对大脑瘤预后.
- 包括每种瘤类型的前100个患者指导的英语结果.
- 使用Flesch阅读方便度,Flesch-Kincaid等级水平,炮火雾指数,科尔曼-利亚乌指数和SMOG指数进行可读性评估.
- 网站内容的比较 (按附属和审查状态分类) 与ChatGPT 4.0响应.
主要成果:
- 没有网站或ChatGPT的响应符合推的可读性基准 (六年级或八年级).
- 大多数网站是在9-12年级 (50.4%) 或本科水平 (47.9%).
- 聊天GPT的响应主要是在研究生水平 (93.3%) 和显示明显较低的可读性比网站 (p < 0.001).
结论:
- 在线和人工智能生成的神经瘤学内容都超过了推的可读性水平.
- 这种缺乏可访问性可能会阻碍患者的理解和决策能力.
- 建议包括标准化指导方针,完善AI内容,确保专业监督,并提高材料的可访问性.
更多相关视频
05:45Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
Published on: January 19, 2024
2.1K
13:12Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
Published on: August 12, 2019
45.8K
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
8.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.2K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
1.7K
The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
1.7K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
